The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation

ObjectivesAlthough human papillomavirus (HPV) infection is considered as a favorable prognostic factor in oropharyngeal cancer, the prognosis of HPV-associated tonsil cancer has rarely been studied especially when surgery was the main treatment. In this study, the authors investigated the effect of...

Full description

Bibliographic Details
Main Authors: Tae Wook Kim, Sung Yong Choi, Young Hyeh Ko, Chung-Hwan Baek, Young-Ik Son
Format: Article
Language:English
Published: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2012-12-01
Series:Clinical and Experimental Otorhinolaryngology
Subjects:
Online Access:http://www.e-ceo.org/upload/pdf/ceo-5-207.pdf
_version_ 1811262299709636608
author Tae Wook Kim
Sung Yong Choi
Young Hyeh Ko
Chung-Hwan Baek
Young-Ik Son
author_facet Tae Wook Kim
Sung Yong Choi
Young Hyeh Ko
Chung-Hwan Baek
Young-Ik Son
author_sort Tae Wook Kim
collection DOAJ
description ObjectivesAlthough human papillomavirus (HPV) infection is considered as a favorable prognostic factor in oropharyngeal cancer, the prognosis of HPV-associated tonsil cancer has rarely been studied especially when surgery was the main treatment. In this study, the authors investigated the effect of p16 over-expression (HPV infection) on tonsil cancer prognosis according to the type of treatment, HPV presence by PCR, and expression of p53 and epidermal growth factor receptor (EGFR) by immunohistochemistry (IHC).MethodsMedical records of 33 tonsil cancer patients were reviewed. Using formalin-fixed and paraffin-embedded tumor specimens, PCR-based genotyping of HPV and IHC of p16, p53 and EGFR were performed. The effects of HPV presence and the expression of IHC markers were analyzed on the recurrence-free survival. Five-year disease-free survival (DFS) rates were evaluated according to p16 expression status.ResultsAn over-expression of p16 was observed in 27 (81.9%) out of 33 cases. Surgery-based treatment was provided for 21 (63.6%) patients. There was no association between p16 immunoreactivity and HPV presence, nor with p53 and EGFR expression. Regardless of main treatment modalities, five-year DFS did not differ by p16 expression status (P=0.051). However, over-expression of p16 was associated with a lower recurrence in multivariable analyses (P=0.046).ConclusionRegardless of main treatment modalities, an over-expression of p16 (HPV infection) is associated with a lower recurrence in tonsil cancers. However it is not associated with simple HPV presence or p53 and EGFR over-expression.
first_indexed 2024-04-12T19:21:39Z
format Article
id doaj.art-7608408ee90241f2b8b26ce213929e51
institution Directory Open Access Journal
issn 1976-8710
2005-0720
language English
last_indexed 2024-04-12T19:21:39Z
publishDate 2012-12-01
publisher Korean Society of Otorhinolaryngology-Head and Neck Surgery
record_format Article
series Clinical and Experimental Otorhinolaryngology
spelling doaj.art-7608408ee90241f2b8b26ce213929e512022-12-22T03:19:34ZengKorean Society of Otorhinolaryngology-Head and Neck SurgeryClinical and Experimental Otorhinolaryngology1976-87102005-07202012-12-015420721210.3342/ceo.2012.5.4.207186The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or RadiationTae Wook Kim0Sung Yong Choi1Young Hyeh Ko2Chung-Hwan Baek3Young-Ik Son4Department of Otorhinolaryngology, Incheon Medical Center, Incheon, Korea.Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ObjectivesAlthough human papillomavirus (HPV) infection is considered as a favorable prognostic factor in oropharyngeal cancer, the prognosis of HPV-associated tonsil cancer has rarely been studied especially when surgery was the main treatment. In this study, the authors investigated the effect of p16 over-expression (HPV infection) on tonsil cancer prognosis according to the type of treatment, HPV presence by PCR, and expression of p53 and epidermal growth factor receptor (EGFR) by immunohistochemistry (IHC).MethodsMedical records of 33 tonsil cancer patients were reviewed. Using formalin-fixed and paraffin-embedded tumor specimens, PCR-based genotyping of HPV and IHC of p16, p53 and EGFR were performed. The effects of HPV presence and the expression of IHC markers were analyzed on the recurrence-free survival. Five-year disease-free survival (DFS) rates were evaluated according to p16 expression status.ResultsAn over-expression of p16 was observed in 27 (81.9%) out of 33 cases. Surgery-based treatment was provided for 21 (63.6%) patients. There was no association between p16 immunoreactivity and HPV presence, nor with p53 and EGFR expression. Regardless of main treatment modalities, five-year DFS did not differ by p16 expression status (P=0.051). However, over-expression of p16 was associated with a lower recurrence in multivariable analyses (P=0.046).ConclusionRegardless of main treatment modalities, an over-expression of p16 (HPV infection) is associated with a lower recurrence in tonsil cancers. However it is not associated with simple HPV presence or p53 and EGFR over-expression.http://www.e-ceo.org/upload/pdf/ceo-5-207.pdfHuman papillomavirusOropharyngeal neoplasmsTherapeuticsImmunohistochemistryPrognosisp16 (INK4A)
spellingShingle Tae Wook Kim
Sung Yong Choi
Young Hyeh Ko
Chung-Hwan Baek
Young-Ik Son
The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
Clinical and Experimental Otorhinolaryngology
Human papillomavirus
Oropharyngeal neoplasms
Therapeutics
Immunohistochemistry
Prognosis
p16 (INK4A)
title The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
title_full The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
title_fullStr The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
title_full_unstemmed The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
title_short The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
title_sort prognostic role of p16 expression in tonsil cancer treated by either surgery or radiation
topic Human papillomavirus
Oropharyngeal neoplasms
Therapeutics
Immunohistochemistry
Prognosis
p16 (INK4A)
url http://www.e-ceo.org/upload/pdf/ceo-5-207.pdf
work_keys_str_mv AT taewookkim theprognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT sungyongchoi theprognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT younghyehko theprognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT chunghwanbaek theprognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT youngikson theprognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT taewookkim prognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT sungyongchoi prognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT younghyehko prognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT chunghwanbaek prognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation
AT youngikson prognosticroleofp16expressionintonsilcancertreatedbyeithersurgeryorradiation